search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
QUICK, COLLABORATIVE MEDICINE


LIFESAVING LINK


Surgeons handle a human acellular vessel during an operation. The off-the-shelf, bioengineered blood vessel is being studied for use in repairing and reconstructing various types of vascular injuries. (Photo courtesy of Humacyte Inc.)


Indeed, for DOD, that kind of capability—to limit blood loss, to restore blood flow to extremities—represents the future: the future of innovation, the future of medicine; in short, the future of a more resilient warfighter. Yet for years, the frustrating snags in DOD’s plan to foster medical innovation were always the twin barbs of speed and collaboration. After all, what exactly is the simplest, most efficient way for an innovative company to dive into the complex world of military medical contracting with designs on creating, testing and finally delivering to the front lines a lifesaving, game-changing product?


Enter the other-transaction agreement.


INCREASED SPEED, FLEXIBILITY In DOD, as everywhere, every second that ticks off the clock brings you one step further into the future and one step closer to your next obstacle. As the nation’s military medical appara- tus prepares for the future battlefield with a variety of concepts, tactics and products, it must also find a way to apply those tools quickly and efficiently, and at a pace likely exceeding those for previous efforts. For the Soldier entering the “future fight” on new and different battlefields—presumed to be thickly populated urban cityscapes where tools will need to be tougher, smaller and better than ever—nothing less will do.


18


In 2014, the U.S. Army Medical Research and Development Command (USAMRDC) received congressional author- ity to begin using a special type of contracting tool called an other-transaction agreement (OTA) to facilitate the delivery of advanced technology and therapeutic prototypes for a wide array of military-relevant injuries. What separates the other-transaction agreement from other standard contracting mechanisms—indeed, its defining characteristic—is that it allows for increased speed and flexibility for both parties.


Notably, it aims to set chosen projects in motion in months as opposed to the generally yearlong time span of standard agree- ments. Tat’s made possible by the other-transaction mechanism’s reliance on typically nontraditional defense contractors and a built-in flexibility in data rights and regulatory terms. Addition- ally, other-transactions allow for more conversation between the military and the performer as compared with traditional Federal Acquisition Regulation-based contracts.


“It’s been exciting to watch the use of OTAs grow and expand at USAMRDC over the past few years,” said Sara Langdon, the command’s program manager (PM) for other-transactions with the Medical Technology Enterprise Consortium. “Te flexibil- ity has allowed for awards that involve complex collaborations


Army AL&T Magazine


Fall 2019


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156